HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olaf Schneewind Selected Research

Staphylococcal Protein A (Protein A)

5/2016Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infection.
1/2015Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.
11/2014Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.
10/2012Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice.
8/2010Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.
10/2009Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olaf Schneewind Research Topics

Disease

59Infections
01/2022 - 02/2002
20Anthrax
01/2020 - 07/2005
17Plague (Bubonic Plague)
10/2019 - 08/2005
12Staphylococcal Infections
05/2016 - 07/2003
11Abscess
01/2016 - 11/2006
9Sepsis (Septicemia)
01/2017 - 10/2011
4Communicable Diseases (Infectious Diseases)
01/2020 - 01/2005
3Infectious Arthritis (Septic Arthritis)
11/2020 - 05/2002
3Staphylococcal Pneumonia
02/2008 - 02/2007
2Endocarditis
01/2018 - 08/2011
2Soft Tissue Infections
01/2016 - 09/2011
2Bacterial Infections (Bacterial Infection)
06/2015 - 02/2006
2Neoplasms (Cancer)
11/2014 - 01/2005
2Bacteremia
08/2010 - 08/2010
1Contracture
11/2020
1Joint Diseases (Joint Disease)
11/2020
1Carcinogenesis
11/2019
1Inflammation (Inflammations)
10/2019
1Endophthalmitis (Ophthalmia)
01/2019
1Rickettsia Infections
01/2019
1Leukemia
11/2014
1Lymphoma (Lymphomas)
11/2014
1Hematologic Neoplasms (Hematological Malignancy)
11/2014
1Clostridium Infections
09/2014
1Persistent Infection
08/2014
1Autolysis
10/2013
1Chronic Kidney Failure (Chronic Renal Failure)
10/2012

Drug/Important Bio-Agent (IBA)

23VaccinesIBA
01/2022 - 08/2005
16Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2002
14AntigensIBA
01/2022 - 03/2005
13AntibodiesIBA
01/2022 - 12/2008
11Anti-Bacterial Agents (Antibiotics)IBA
11/2020 - 11/2006
9IronIBA
10/2012 - 01/2004
9Membrane Proteins (Integral Membrane Proteins)IBA
01/2010 - 02/2002
8FibrinIBA
03/2016 - 08/2010
712- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
11/2020 - 08/2010
6Virulence Factors (Pathogenicity Factors)IBA
11/2020 - 07/2003
6Staphylococcal Protein A (Protein A)IBA
05/2016 - 10/2009
6Peptidoglycan (Murein)IBA
05/2016 - 01/2009
6Heme (Haem)IBA
08/2010 - 01/2004
5CoagulaseIBA
11/2020 - 01/2012
5Capsules (Microcapsules)IBA
01/2016 - 04/2008
5Pharmaceutical PreparationsIBA
11/2014 - 01/2009
5Peptides (Polypeptides)IBA
04/2012 - 02/2002
4Carrier Proteins (Binding Protein)IBA
11/2020 - 01/2012
4von Willebrand FactorIBA
11/2020 - 01/2012
4EnzymesIBA
12/2015 - 07/2003
4Hemolysin Proteins (Hemolysins)IBA
10/2012 - 12/2007
4Subunit VaccinesIBA
10/2012 - 05/2008
3Neutralizing AntibodiesIBA
01/2021 - 03/2013
3Coenzyme A (CoA)IBA
11/2020 - 01/2012
3Polysaccharides (Glycans)IBA
01/2020 - 04/2011
3Monoclonal AntibodiesIBA
01/2020 - 02/2010
3Adenosine (Adenocard)FDA LinkGeneric
01/2018 - 10/2009
3CytokinesIBA
01/2017 - 08/2005
3Fibrinogen (Factor I)FDA Link
03/2016 - 01/2012
3Glutamic Acid (Glutamate)FDA Link
06/2015 - 04/2008
3Prothrombin (Factor II)IBA
10/2012 - 08/2010
2SuperantigensIBA
01/2021 - 02/2012
2Complement System Proteins (Complement)IBA
01/2020 - 03/2014
2Type III Secretion SystemsIBA
10/2019 - 01/2012
2CalciumIBA
01/2016 - 08/2005
2S-layer proteinsIBA
08/2014 - 09/2010
2DabigatranFDA Link
07/2013 - 10/2011
2Plague VaccineIBA
10/2012 - 08/2006
2Panton-Valentine leukocidinIBA
09/2011 - 12/2007
2EpitopesIBA
02/2010 - 03/2009
2Biological Warfare AgentsIBA
01/2009 - 05/2008
2Interleukin-10 (Interleukin 10)IBA
10/2008 - 08/2005
2Hemoglobins (Hemoglobin)IBA
08/2008 - 02/2006
2GlycolipidsIBA
03/2007 - 03/2005
1Caspase 3 (Caspase-3)IBA
11/2019
1O Antigens (O Antigen)IBA
01/2019
12'-deoxyadenosineIBA
01/2018
1Micrococcal NucleaseIBA
01/2018
1TrisaccharidesIBA
01/2018
1Interleukin-12 (IL 12)IBA
01/2017
1ribosomal protein S3IBA
01/2017
1Codon (Codons)IBA
01/2017
1DisulfidesIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Glutathione (Reduced Glutathione)IBA
01/2017
1Glutathione Synthase (Glutathione Synthetase)IBA
01/2017
1Retinaldehyde (Retinal)IBA
01/2017
1Glutathione Disulfide (GSSG)FDA LinkGeneric
01/2017
1factor AIBA
01/2016
1glutamate racemaseIBA
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2014
1Serine (L-Serine)FDA Link
02/2014
1Aspartic Acid (Aspartate)FDA Link
02/2014
1HydrolasesIBA
10/2013
1staphylothrombinIBA
07/2013
1Hyaluronic Acid (Hyaluronan)IBA
02/2013
1Attenuated VaccinesIBA
10/2012

Therapy/Procedure

8Therapeutics
01/2022 - 01/2009
3Catheters
10/2019 - 07/2013
2Immunotherapy
01/2022 - 11/2014
2Drug Therapy (Chemotherapy)
11/2014 - 03/2004
2Continuous Ambulatory Peritoneal Dialysis (CAPD)
10/2012 - 01/2009
1Lasers (Laser)
01/2019